MicroRNA expression profiles in Kaposi's sarcoma
- PMID: 24027049
- DOI: 10.1007/s12253-013-9678-1
MicroRNA expression profiles in Kaposi's sarcoma
Abstract
Kaposi's sarcoma (KS) is a mesenchymal tumor, caused by Human herpesvirus 8 (HHV8) with molecular and cytogenetic changes poorly understood. To gain further insight on the underlying molecular changes in KS, we performed microRNA (miRNA) microarray analysis of 17 Kaposi's sarcoma specimens. Three normal skin specimens were used as controls. The most significant differentially expressed miRNA were confirmed by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). We detected in KS versus normal skin 185 differentially expressed miRNAs, 76 were upregulated and 109 were downregulated. The most significantly downregulated miRNAs were miR-99a, miR-200 family, miR-199b-5p, miR-100 and miR-335, whereas kshv-miR-K12-4-3p, kshv-miR-K12-1, kshv-miR-K12-2, kshv-miR-K12-4-5p and kshv-miR-K12-8 were significantly upregulated. High expression levels of kshv-miR-K12-1 (p = 0.004) and kshv-miR-K12-4-3p (p = 0.001) was confirmed by RT-PCR. The predicted target genes for differentially expressed miRNAs included genes which are involved in a variety of cellular processes such as angiogenesis (i.e. THBS1) and apoptosis (i.e. CASP3, MCL1), suggesting a role for these miRNAs in Kaposi's sarcoma pathogenesis.
Similar articles
-
The expression profiles of microRNAs in Kaposi's sarcoma.Tumour Biol. 2015 Jan;36(1):437-46. doi: 10.1007/s13277-014-2626-1. Epub 2014 Oct 1. Tumour Biol. 2015. PMID: 25266797
-
Kaposi's sarcoma-associated herpes virus-derived microRNA K12-1 over-activates the PI3K/Akt pathway to facilitate cancer progression in HIV-related gastrointestinal Kaposi's sarcoma.SLAS Discov. 2022 Jun;27(4):258-265. doi: 10.1016/j.slasd.2022.04.001. Epub 2022 Apr 10. SLAS Discov. 2022. PMID: 35413475
-
miRNA Sequence Analysis in Patients With Kaposi's Sarcoma-Associated Herpesvirus.Pathol Oncol Res. 2022 Jan 24;28:1610055. doi: 10.3389/pore.2022.1610055. eCollection 2022. Pathol Oncol Res. 2022. PMID: 35140551 Free PMC article.
-
KSHV microRNAs: Tricks of the Devil.Trends Microbiol. 2017 Aug;25(8):648-661. doi: 10.1016/j.tim.2017.02.002. Epub 2017 Mar 2. Trends Microbiol. 2017. PMID: 28259385 Free PMC article. Review.
-
Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8: a new virus in human pathology.J Am Acad Dermatol. 1997 Jul;37(1):107-13. doi: 10.1016/s0190-9622(97)70220-2. J Am Acad Dermatol. 1997. PMID: 9216532 Review.
Cited by
-
Pathogens Use and Abuse MicroRNAs to Deceive the Immune System.Int J Mol Sci. 2016 Apr 9;17(4):538. doi: 10.3390/ijms17040538. Int J Mol Sci. 2016. PMID: 27070595 Free PMC article. Review.
-
Polymorphisms in KSHV-encoded microRNA sequences affect levels of mature viral microRNA in Kaposi Sarcoma lesions.Oncotarget. 2018 Nov 9;9(88):35856-35869. doi: 10.18632/oncotarget.26321. eCollection 2018 Nov 9. Oncotarget. 2018. PMID: 30533200 Free PMC article.
-
A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.Oncogene. 2017 Sep 21;36(38):5407-5420. doi: 10.1038/onc.2017.139. Epub 2017 May 22. Oncogene. 2017. PMID: 28534512 Free PMC article.
-
Differential expression of microRNAs in the normal skin of the Han and Uyghur populations in Xinjiang Province.Medicine (Baltimore). 2018 Feb;97(7):e9928. doi: 10.1097/MD.0000000000009928. Medicine (Baltimore). 2018. PMID: 29443776 Free PMC article.
-
MicroRNA miR-21 attenuates human cytomegalovirus replication in neural cells by targeting Cdc25a.J Virol. 2015 Jan 15;89(2):1070-82. doi: 10.1128/JVI.01740-14. Epub 2014 Nov 5. J Virol. 2015. PMID: 25378484 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous